793 related articles for article (PubMed ID: 11597586)
1. C-FOS expression in the rat brain in response to substance P and neurokinin B.
Spitznagel H; Baulmann J; Blume A; Unger T; Culman J
Brain Res; 2001 Oct; 916(1-2):11-21. PubMed ID: 11597586
[TBL] [Abstract][Full Text] [Related]
2. Tachykinin receptor inhibition and c-Fos expression in the rat brain following formalin-induced pain.
Baulmann J; Spitznagel H; Herdegen T; Unger T; Culman J
Neuroscience; 2000; 95(3):813-20. PubMed ID: 10670449
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists.
Picard P; Regoli D; Couture R
Br J Pharmacol; 1994 May; 112(1):240-9. PubMed ID: 7518304
[TBL] [Abstract][Full Text] [Related]
4. Effects of the tachykinin NK1 receptor antagonist, RP 67580, on central cardiovascular and behavioural effects of substance P, neurokinin A and neurokinin B.
Culman J; Wiegand B; Spitznagel H; Klee S; Unger T
Br J Pharmacol; 1995 Mar; 114(6):1310-6. PubMed ID: 7542533
[TBL] [Abstract][Full Text] [Related]
5. Distribution of Fos-like immunoreactivity in guinea-pig brain following administration of the neurokinin-1 receptor agonist, [SAR9,MET(O2)11]substance P.
Yip J; Chahl LA
Neuroscience; 1999; 94(2):663-73. PubMed ID: 10579226
[TBL] [Abstract][Full Text] [Related]
6. Are biological actions of neurokinin A in the adult brain mediated by a cross-talk between the NK1 and NK2 receptors?
Tauer U; Zhao Y; Hunt SP; Culman J
Neuropharmacology; 2012 Nov; 63(6):958-65. PubMed ID: 22771977
[TBL] [Abstract][Full Text] [Related]
7. Modulation of cardiac activity by tachykinins in the rat substantia nigra.
Lessard A; Couture R
Br J Pharmacol; 2001 Dec; 134(8):1749-59. PubMed ID: 11739252
[TBL] [Abstract][Full Text] [Related]
8. Localization of Fos-like immunoreactivity induced by the NK3 tachykinin receptor agonist, senktide, in the guinea-pig brain.
Yip J; Chahl LA
Br J Pharmacol; 1997 Oct; 122(4):715-25. PubMed ID: 9375969
[TBL] [Abstract][Full Text] [Related]
9. Distribution of Fos-like immunoreactivity within the rat brain following intraventricular injection of the selective NK(3) receptor agonist senktide.
Smith ME; Flynn FW
J Comp Neurol; 2000 Oct; 426(3):413-28. PubMed ID: 10992247
[TBL] [Abstract][Full Text] [Related]
10. Effect of tachykinin receptor inhibition in the brain on cardiovascular and behavioral responses to stress.
Culman J; Klee S; Ohlendorf C; Unger T
J Pharmacol Exp Ther; 1997 Jan; 280(1):238-46. PubMed ID: 8996202
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular and behavioural effects of intracerebroventricularly administered tachykinin NK3 receptor antagonists in the conscious rat.
Cellier E; Barbot L; Regoli D; Couture R
Br J Pharmacol; 1997 Oct; 122(4):643-54. PubMed ID: 9375960
[TBL] [Abstract][Full Text] [Related]
12. Respiratory actions of tachykinins in the nucleus of the solitary tract: characterization of receptors using selective agonists and antagonists.
Mazzone SB; Geraghty DP
Br J Pharmacol; 2000 Mar; 129(6):1121-31. PubMed ID: 10725260
[TBL] [Abstract][Full Text] [Related]
13. The ventral tegmental area as a putative target for tachykinins in cardiovascular regulation.
Deschamps K; Couture R
Br J Pharmacol; 2005 Jul; 145(6):712-27. PubMed ID: 15895109
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular and behavioural effects induced by naloxone-precipitated morphine withdrawal in rat: characterization with tachykinin antagonists.
Michaud N; Couture R
Neuropeptides; 2003 Dec; 37(6):345-54. PubMed ID: 14698677
[TBL] [Abstract][Full Text] [Related]
15. Blockade of tachykinin NK1/NK2 receptors in the brain attenuates the activation of corticotrophin-releasing hormone neurones in the hypothalamic paraventricular nucleus and the sympathoadrenal and pituitary-adrenal responses to formalin-induced pain in the rat.
Culman J; Das G; Ohlendorf C; Haass M; Maser-Gluth C; Zuhayra M; Zhao Y; Itoi K
J Neuroendocrinol; 2010 May; 22(5):467-76. PubMed ID: 20210847
[TBL] [Abstract][Full Text] [Related]
16. Neurokinin B receptor (NK3)-containing neurons in the paraventricular and supraoptic nuclei of the rat hypothalamus synthesize vasopressin and express Fos following intravenous injection of hypertonic saline.
Ding YQ; Lü BZ; Guan ZL; Wang DS; Xu JQ; Li JH
Neuroscience; 1999; 91(3):1077-85. PubMed ID: 10391485
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular and behavioural effects of centrally administered neuropeptide K in the rat: receptor characterization.
Prat A; Picard P; Couture R
Br J Pharmacol; 1994 May; 112(1):250-6. PubMed ID: 7518305
[TBL] [Abstract][Full Text] [Related]
18. Effects of selective tachykinin-receptor antagonists on tachykinin-induced airway mucus secretion in the rat.
Wagner U; Fehmann H; Bredenbröker D; Klüber D; Lange A; Wichert P
Neuropeptides; 1999 Feb; 33(1):55-61. PubMed ID: 10657472
[TBL] [Abstract][Full Text] [Related]
19. Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord.
Fox AJ; Naeem S; Patel IA; Walpole C; Urbán L
Acta Biol Hung; 1996; 47(1-4):129-44. PubMed ID: 9123986
[TBL] [Abstract][Full Text] [Related]
20. Secretin activates visceral brain regions in the rat including areas abnormal in autism.
Welch MG; Keune JD; Welch-Horan TB; Anwar N; Anwar M; Ruggiero DA
Cell Mol Neurobiol; 2003 Oct; 23(4-5):817-37. PubMed ID: 14514034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
